National Institutes Of Health 1
1. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
2. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
3. Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017-2022
4. Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study
5. Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
6. Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) (npj Parkinsons Disease, (2023), 9, 1, (100), 10.1038/s41531-023-00526-9)
7. The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
8. Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
9. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
10. Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores
11. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
12. TMEM175, SCARB2 and CTSB associations with Parkinson’s disease risk across populations
13. Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
14. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
1